APH
64
3
TGNA
53
-3
MTCH
40
-10
BLK
63
-4
T
45
-2
HSIC
57
4
UA
56
3
CTSH
56
4
ADT
37
4
WAT
61
-3
FLS
73
4
URBN
70
-2
BA
65
2
CLX
65
-4
LRCX
65
6
DFS
71
4
DGX
29
-3
AME
54
-5
TSN
32
-3
VRSK
63
-3
APH
64
3
TGNA
53
-3
MTCH
40
-10
BLK
63
-4
T
45
-2
HSIC
57
4
UA
56
3
CTSH
56
4
ADT
37
4
WAT
61
-3
FLS
73
4
URBN
70
-2
BA
65
2
CLX
65
-4
LRCX
65
6
DFS
71
4
DGX
29
-3
AME
54
-5
TSN
32
-3
VRSK
63
-3
Financhill
Back

First Capital Vs. Aligos Therapeutics Industry Stock Comparison

Sell
46

FCAP
First Capital

Last Price:
30.21
Seasonality Move:
2.68%
Buy
75

ALGS
Aligos Therapeutics

Last Price:
34.20
Seasonality Move:
10.65%
Sell
46
First Capital (FCAP) is a Sell

Is First Capital a Buy, Sell or Hold?

  • The current First Capital [FCAP] share price is $30.80. The Score for FCAP is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • FCAP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
75
Aligos Therapeutics (ALGS) is a Buy

Is Aligos Therapeutics a Buy, Sell or Hold?

  • The current Aligos Therapeutics [ALGS] share price is $34.53. The Score for ALGS is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
  • ALGS is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

FCAP Stock Price Chart

What is First Capital's stock price today?

  • The First Capital share price today is $30.80
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FCAP is experiencing buying pressure, which is a positive indicator for future bullish movement.

ALGS Stock Price Chart

What is Aligos Therapeutics's stock price today?

  • The Aligos Therapeutics share price today is $34.53
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALGS is experiencing buying pressure, which is a positive indicator for future bullish movement.

FCAP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.99 Sell
Relative Strength Index (14 RSI): 36.63 Sell
Chaikin Money Flow: 2849 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (31.41 - 34.35) Sell
Bollinger Bands (100): (31.22 - 35.2) Sell

ALGS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.71 Buy
Relative Strength Index (14 RSI): 85.17 Buy
Chaikin Money Flow: 491004 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (15.08 - 27.66) Buy
Bollinger Bands (100): (7.67 - 19.61) Buy

FCAP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 31.37 Sell
20-day SMA: 32.39 Sell
50-day SMA: 34.2 Sell
200-day SMA: 31.04 Sell
8-day EMA: 31.23 Sell
20-day EMA: 32.25 Sell
50-day EMA: 33.19 Sell
200-day EMA: 31.67 Sell

ALGS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 28.48 Buy
20-day SMA: 23.64 Buy
50-day SMA: 14.76 Buy
200-day SMA: 15.86 Buy
8-day EMA: 28.77 Buy
20-day EMA: 23.99 Buy
50-day EMA: 18.16 Buy
200-day EMA: 16.13 Buy

First Capital Earnings Growth & FCAP Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Aligos Therapeutics Earnings Growth & ALGS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $30.89 per share, and a decrease next year of $2.65 per share.

First Capital Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Aligos Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):